| T cell subsets and functions in atherosclerosis | 2020/03/16 | English | 346 |
| Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis | 2015/10/27 | English | 341 |
| Environmental determinants of cardiovascular disease: lessons learned from air pollution | 2020/05/07 | English | 340 |
| Socioeconomic status and cardiovascular disease: risks and implications for care | 2009/09/22 | English | 339 |
| Extracellular vesicles in coronary artery disease | 2017/02/02 | English | 334 |
| Counter-regulatory renin–angiotensin system in cardiovascular disease | 2019/08/19 | English | 333 |
| Coronary microvascular dysfunction: mechanisms and functional assessment | 2014/10/14 | English | 333 |
| Mechanisms of vascular damage in obstructive sleep apnea | 2010/09/28 | English | 332 |
| Interplay between inflammation and thrombosis in cardiovascular pathology | 2021/05/06 | English | 328 |
| Neurohormonal activation in heart failure with reduced ejection fraction | 2016/10/06 | English | 324 |
| Evaluation and management of heart failure with preserved ejection fraction | 2020/03/30 | English | 314 |
| Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia | 2020/03/30 | English | 313 |
| Inflammatory processes in cardiovascular disease: a route to targeted therapies | 2016/12/01 | English | 307 |
| PPAR control of metabolism and cardiovascular functions | 2021/06/14 | English | 303 |
| Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | 2014/04/29 | English | 290 |
| NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets | 2019/10/07 | English | 289 |
| Global epidemiology of dyslipidaemias | 2021/04/08 | English | 280 |
| Postoperative atrial fibrillation: mechanisms, manifestations and management | 2019/02/21 | English | 279 |
| The role of adipose tissue in cardiovascular health and disease | 2018/10/04 | English | 275 |
| The importance of the endothelium in atherothrombosis and coronary stenting | 2012/05/22 | English | 271 |
| Anti-inflammatory therapies for atherosclerosis | 2015/02/10 | English | 270 |
| Epidemiology and treatment of pulmonary arterial hypertension | 2017/06/08 | English | 270 |
| A major role for cardiovascular burden in age-related cognitive decline | 2015/01/13 | English | 267 |
| Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases | 2021/02/22 | English | 267 |
| Artificial intelligence-enhanced electrocardiography in cardiovascular disease management | 2021/02/01 | English | 264 |
| Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | 2020/11/19 | English | 262 |
| Smart wearable devices in cardiovascular care: where we are and how to move forward | 2021/03/04 | English | 261 |
| Sudden cardiac death: epidemiology and risk factors | 2010/02/09 | English | 261 |
| Regulatory T cells in cardiovascular diseases | 2015/11/03 | English | 259 |
| PET imaging of inflammation in atherosclerosis | 2014/06/10 | English | 257 |